87390143

Information

  • Trademark
  • 87390143
  • Serial Number
    87390143
  • Registration Number
    5788300
  • Filing Date
    March 29, 2017
    7 years ago
  • Registration Date
    June 25, 2019
    5 years ago
  • Transaction Date
    June 25, 2024
    2 months ago
  • Status Date
    June 25, 2019
    5 years ago
  • Published for Opposition Date
    February 20, 2018
    6 years ago
  • Location Date
    June 03, 2022
    2 years ago
  • First Use Anywhere Date
    January 01, 2016
    8 years ago
  • First Use In Commerce Date
    January 01, 2016
    8 years ago
  • Status Code
    700
  • Current Location
    TMO LAW OFFICE 124
    Employee Name
    BHUPATHI, TARA LUISE
  • Attorney Docket Number
    3814.0250000
    Attorney Name
    Monica Riva Talley
    Law Office Assigned Location Code
    N60
  • Owners
Mark Drawing Code
2
Case File Statements
  • DM0000: The mark consists of starburst patterned logo with eight points.
  • A00001: Issue New Certificate to: BioNTech US Inc. (Delaware corporation) 40 Erie Street, Suite 110, Cambridge MA 02139.
  • GS0051: Pharmaceuticals, namely, immunotherapies for the treatment of cancer and oncological conditions; oncological preparations, namely, pharmaceutical products for the detection, prevention, and treatment of cancer; anti-cancer preparations; biological preparations for the treatment of cancer and oncological conditions; pharmaceutical products for the prevention and treatment of cancer and oncological conditions; synthetic peptides for the treatment of cancer and oncological conditions; and vaccine preparations
  • CC0000: Color is not claimed as a feature of the mark.
  • GS0441: Medical and pharmaceutical consultation; and providing information relating to therapeutic properties of pharmaceuticals
  • GS0421: Conducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of biotechnology and pharmaceutical research; pharmaceutical product development services; pharmaceutical product evaluation services; pharmaceutical research and development; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development of pharmaceuticals for the treatment of cancer and oncological conditions; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platform for manufacturing therapeutics; conducting clinical trials for others in the field of pharmaceuticals for the treatment and prevention of cancer and oncological conditions; and consulting services for others in the field of design, planning, and implementation of clinical trials
Case File Event Statements
  • 6/28/2017 - 7 years ago
    5 - PRIORITY ACTION WRITTEN Type: CPRA
  • 4/1/2017 - 7 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 4/4/2017 - 7 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 4/5/2017 - 7 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 6/21/2017 - 7 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 1/10/2018 - 6 years ago
    15 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 6/28/2017 - 7 years ago
    6 - PRIORITY ACTION E-MAILED Type: GPRA
  • 6/28/2017 - 7 years ago
    7 - NOTIFICATION OF PRIORITY ACTION E-MAILED Type: GPRN
  • 12/22/2017 - 6 years ago
    8 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 12/22/2017 - 6 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/23/2017 - 6 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/22/2017 - 6 years ago
    11 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 1/10/2018 - 6 years ago
    12 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 1/10/2018 - 6 years ago
    13 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 1/10/2018 - 6 years ago
    14 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 1/10/2018 - 6 years ago
    16 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 10/18/2018 - 5 years ago
    24 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 1/31/2018 - 6 years ago
    17 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/20/2018 - 6 years ago
    18 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 2/20/2018 - 6 years ago
    19 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 4/17/2018 - 6 years ago
    20 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 10/16/2018 - 5 years ago
    21 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 10/16/2018 - 5 years ago
    22 - SOU EXTENSION 1 FILED Type: EXT1
  • 10/16/2018 - 5 years ago
    23 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 10/16/2018 - 5 years ago
    25 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 4/11/2019 - 5 years ago
    26 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 5/18/2019 - 5 years ago
    30 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR
  • 5/21/2019 - 5 years ago
    31 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA
  • 6/25/2019 - 5 years ago
    32 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 1/6/2022 - 2 years ago
    33 - TEAS SECTION 7 REQUEST RECEIVED Type: ES7R
  • 4/11/2019 - 5 years ago
    28 - USE AMENDMENT FILED Type: IUAF
  • 4/24/2019 - 5 years ago
    27 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 4/24/2019 - 5 years ago
    29 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 6/2/2022 - 2 years ago
    34 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 6/3/2022 - 2 years ago
    35 - NEW CERTIFICATE UNDER SECTION 7 - PROCESSED Type: C.7C
  • 6/25/2024 - 2 months ago
    36 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1